Topic: Renal and Urogenital
Conditions
Interventions
Patients will be identified through routine blood tests to measure kidney function collected during their hospital stay. They will be invited to participate in the study at least two months after thes
the second at 9 months (1 year after the AKI) and the third at 33 months (three years after the AKI). These samples can be collected in the community at the patients GP surgery or local blood-taking c
Sponsors
Derby Hospital NHS Foundation Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18-85 years 2. Recent inpatient at Royal Derby Hospital during which a blood test was sent to assess kidney function, and was classified either as AKI or as NAKI (screened for possible AKI but who did not sustain AKI)
Exclusion criteria
Exclusion criteria: 1. Inability/refusal to give informed consent to participate 2. Language barrier that prevents informed postal consent 3. Death during the same hospital admission that AKI occurred 4. Receiving palliative care
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 28/03/2017: Mortality, progression to a combined renal end point (initiation of RRT, GFR<15ml/min/1.73m2, doubling of serum creatinine) at one, three, five and ten years. Previous primary outcome measures: CKD progression; Timepoint(s): 1 year and 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 28/03/2017: CKD progession defined as =25% decline in eGFR plus decline in eGFR stage measred at one, three and five years. Previous secondary outcome measures: Mortality; Timepoint(s): 1, 3 and 5 years | — |
Countries
England, United Kingdom
Outcome results
None listed